HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness.

Caccuri, Francesca; Giordano, Francesca; Barone, Ines; Mazzuca, Pietro; Giagulli, Cinzia; Andò, Sebastiano; Caruso, Arnaldo; Marsico, Stefania

Caccuri, Francesca; Giordano, Francesca; Barone, Ines; Mazzuca, Pietro; Giagulli, Cinzia; Andò, Sebastiano; Caruso, Arnaldo; Marsico, Stefania.

Afiliação

Caccuri F; Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia , Brescia, Italy.
Giordano F; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Italy.
Barone I; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Italy.
Mazzuca P; Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia , Brescia, Italy.
Giagulli C; Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia , Brescia, Italy.
Andò S; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Italy.
Caruso A; Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia , Brescia, Italy.
Marsico S; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Italy.

Infect Agent Cancer ; 12: 49, 2017.

Article em En | MEDLINE | ID: mdl-29021819

Palavras-chave

Breast cancer; Clonogenicity; ERK1/2 signaling pathway; HIV-1 matrix protein p17; Motility; p17 variants

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Agent Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google